Rapid Micro Biosystems (RPID) Change in Receivables (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Change in Receivables of $3.2 million for Q1 2026, up 207.84% on a YoY basis from $1.1 million in Q1 2025, and up 240.69% sequentially from -$2.3 million in Q4 2025.
Rapid Micro Biosystems (RPID) Change in Receivables (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Change in Receivables data on file, last reported at $3.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 207.84% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 561.0% YoY), and the FY2025 full-year result was -$4.4 million, down 320.79% from the prior year.
- Change in Receivables advanced to $3.2 million in Q1 2026, from -$2.3 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $3.8 million in Q4 2024 to a low of -$3.0 million in Q1 2025.
- A 5-year average of $80000.0 and a median of $142000.0 in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables jumped 71100.0% in 2022 and slumped 878.41% in 2023, its largest moves.
- Tracing RPID's Change in Receivables over 5 years: stood at $710000.0 in 2022, then jumped by 128.87% to $1.6 million in 2023, then soared by 132.55% to $3.8 million in 2024, then slumped by 160.81% to -$2.3 million in 2025, then surged by 240.69% to $3.2 million in 2026.
- Business Quant data shows RPID's Change in Receivables at $3.2 million in Q1 2026, -$2.3 million in Q4 2025, and -$618000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.23 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | -618,000.00 |
| Sep 30, 2025 | -618,000.00 |
| Jun 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Sep 30, 2024 | -1.27 Mn |
| Sep 30, 2024 | -1.27 Mn |
| Jun 30, 2024 | 90,000.00 |
| Jun 30, 2024 | 90,000.00 |
| Mar 31, 2024 | -611,000.00 |
| Mar 31, 2024 | -611,000.00 |
| Dec 31, 2023 | 1.63 Mn |
| Dec 31, 2023 | 1.63 Mn |